Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-23 5:09 PM View:  | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 483,741 | -- | -- | (100%) 483.74K to 0 | |
| 15-Jun-23 4:39 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 36% 46.59K to 63.34K | |
| 01-Dec-22 4:01 PM View: | Opexa Therapeutics, Inc. (ACER) | 29-Nov-22 | Private Purchase | 409,836 | $1.22 | $500,000.00 | 555% 73.91K to 483.74K | |
| 09-Jun-22 4:36 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Jun-22 | Grant | 12,866 | -- | -- | 38% 33.73K to 46.59K | |
| 02-Jun-22 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-22 | Grant | 569 | $9.31 | $5,297.39 | 2% 33.16K to 33.73K | |
| 12-May-22 8:35 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Sale | 2,575 | $21.92 | $56,456.60 | (2%) 149.49K to 146.92K | |
| 02-Mar-22 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-22 | Grant | 301 | $16.61 | $4,999.61 | < 1% 32.86K to 33.16K | |
| 13-Dec-21 4:02 PM View: | Opexa Therapeutics, Inc. (ACER) | 10-Dec-21 | Market Purchase | 7,984 | $2.04 | $16,287.40 | 12% 65.92K to 73.91K | < 1% |
| 13-Dec-21 4:02 PM View: | Opexa Therapeutics, Inc. (ACER) | 09-Dec-21 | Market Purchase | 2,016 | $2.15 | $4,334.40 | 3% 63.91K to 65.92K | (4%) |
| 02-Dec-21 4:15 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-21 | Grant | 414 | $12.06 | $4,992.84 | 1% 32.44K to 32.86K | (7%) |
| 18-Nov-21 4:08 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Nov-21 | Market Sale (Planned) | 31,800 | $29.39 | $934,602.00 | (18%) 181.29K to 149.49K | (< 1%) |
| 09-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Nov-21 | Option Exercise | 10,000 | $16.23 | $162,300.00 | 6% 181.29K to 191.29K | |
| 09-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Nov-21 | Planned Option Sale | 10,000 | $26.23 | $262,300.00 | (5%) 191.29K to 181.29K | |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Nov-21 | Market Sale (Planned) | 3,500 | $30.00 | $105,000.00 | (2%) 184.79K to 181.29K | |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Nov-21 | Market Sale (Planned) | 5,000 | $29.48 | $147,400.00 | (3%) 189.79K to 184.79K | |
| 08-Oct-21 4:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 07-Oct-21 | Option Exercise | 60,000 | $16.23 | $973,800.00 | 32% 189.79K to 249.79K | |
| 08-Oct-21 4:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 07-Oct-21 | Market Option Sale (Planned) | 60,000 | $26.25 | $1,574,760.00 | (24%) 249.79K to 189.79K | |
| 02-Sep-21 4:28 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-21 | Grant | 314 | $15.92 | $4,998.88 | < 1% 32.13K to 32.44K | 1% |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Jul-21 | Gift | 3,000 | -- | -- | 2% 189.79K to 192.79K | |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Jul-21 | Gift | 3,000 | -- | -- | (2%) 192.79K to 189.79K | |
| 01-Jun-21 4:16 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-May-21 | Grant | 634 | $15.77 | $9,998.18 | 2% 31.5K to 32.13K | 0% |
| 18-May-21 9:21 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-21 | Grant | 3,000 | -- | -- | 2% 186.79K to 189.79K | |
| 13-May-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-21 | Market Sale | 2,146 | $19.58 | $42,023.00 | (1%) 188.94K to 186.79K | (1%) |
| 20-Apr-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Apr-21 | Option Exercise | 10,000 | $16.23 | $162,300.00 | 5% 188.94K to 198.94K | |
| 20-Apr-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Apr-21 | Market Option Sale (Planned) | 10,000 | $26.23 | $262,300.00 | (5%) 198.94K to 188.94K | |
| 19-Mar-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Mar-21 | Option Exercise | 10,000 | $16.23 | $162,300.00 | 5% 196.67K to 206.67K | |
| 19-Mar-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Mar-21 | Market Option Sale (Planned) | 10,000 | $27.44 | $274,415.00 | (5%) 206.67K to 196.67K | |
| 19-Mar-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Mar-21 | Market Sale (Planned) | 7,727 | $27.44 | $212,041.00 | (4%) 196.67K to 188.94K | |
| 02-Mar-21 4:47 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 26-Feb-21 | Grant | 927 | $10.78 | $9,993.06 | 3% 30.57K to 31.5K | 11% |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Feb-21 | Gift | 25,000 | -- | -- | 13% 189.79K to 214.79K | |
| 03-Nov-21 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Feb-21 | Gift | 25,000 | -- | -- | (12%) 214.79K to 189.79K | |
| 02-Feb-21 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Option Exercise | 25,000 | $10.09 | $252,250.00 | 13% 196.67K to 221.67K | |
| 02-Feb-21 9:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Option Sale (Planned) | 25,000 | $30.75 | $768,750.00 | (11%) 221.67K to 196.67K | |
| 16-Dec-20 8:55 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-Dec-20 | Market Sale | 5,549 | $26.02 | $144,385.00 | (3%) 202.22K to 196.67K | |
| 04-Dec-20 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Dec-20 | Market Sale | 7,891 | $23.43 | $184,849.00 | (4%) 210.11K to 202.22K | |
| 02-Dec-20 4:19 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-20 | Grant | 1,956 | $5.11 | $9,995.16 | 7% 28.61K to 30.57K | 49% |
| 04-Dec-20 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 19-Nov-20 | Gift | 3,000 | -- | -- | (1%) 213.11K to 210.11K | |
| 06-Nov-20 8:56 PM View: | Travere Therapeutics, Inc. (TVTX) | 06-Nov-20 | Market Sale (Planned) | 20,625 | $23.00 | $474,375.00 | (9%) 233.73K to 213.11K | |
| 06-Nov-20 8:56 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Nov-20 | Market Sale (Planned) | 2,500 | $21.26 | $53,150.00 | (1%) 236.23K to 233.73K | |
| 02-Sep-20 4:36 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-20 | Grant | 2,409 | $4.15 | $9,997.35 | 9% 26.2K to 28.61K | 83% |
| 06-Aug-20 4:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Aug-20 | Market Sale (Planned) | 2,500 | $19.68 | $49,200.00 | (1%) 238.73K to 236.23K | 2% |
| 28-Jul-20 9:02 AM View: | Opexa Therapeutics, Inc. (ACER) | 24-Jul-20 | Market Purchase | 45,000 | $3.50 | $157,500.00 | 238% 18.91K to 63.91K | (27%) |
| 29-Jun-20 9:02 PM View: | Travere Therapeutics, Inc. (TVTX) | 25-Jun-20 | Market Sale (Planned) | 10,000 | $20.00 | $200,000.00 | (4%) 248.73K to 238.73K | 3% |
| 03-Jun-20 4:24 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-20 | Grant | 1,112 | $4.49 | $4,998.44 | 4% 25.09K to 26.2K | 69% |
| 19-May-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-20 | Grant | 3,000 | -- | -- | 1% 245.73K to 248.73K | |
| 14-May-20 8:59 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-20 | Market Sale (Planned) | 3,062 | $15.09 | $46,205.60 | (1%) 248.79K to 245.73K | |
| 14-May-20 8:59 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-May-20 | Market Sale (Planned) | 4,063 | $16.41 | $66,673.80 | (2%) 252.86K to 248.79K | |
| 14-May-20 8:59 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale (Planned) | 1,000 | $17.16 | $17,160.00 | (< 1%) 253.86K to 252.86K | |
| 06-May-20 4:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-May-20 | Market Sale (Planned) | 2,500 | $15.88 | $39,700.00 | (< 1%) 256.36K to 253.86K | |
| 09-Mar-20 9:03 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Grant | 12,250 | -- | -- | 5% 248.47K to 260.72K |